A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.
PubMedPublished 15 June 2003
Thomas Wirth, Lars Zender, Bernd Schulte, Bettina Mundt, Ruben R. Plentz, K. Lenhard Rudolph
Citations171
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Results demonstrate that expression of E1A under transcriptional control of the hTERT promoter is sufficient for effective telomerase-dependent adenovirus replication as a promising perspective for the treatment of the majority of epithelial tumors.
Abstract
The catalytic component of human telomerase reverse transcriptase (hTERT) is not expressed in most primary somatic human cells, whereas the majority of cancer cells reactivate telomerase by transcriptional up-regulation of hTERT. Several studies demonstrated that the hTERT promoter can be used to restrict gene expression of E1-deleted replication defective adenoviral vectors to telomerase-positive cancer cells. In this study, a conditionally replicating adenovirus (hTERT-Ad) expressing E1A genes under control of a 255-bp hTERT-promoter was constructed. Additionally, an internal ribosomal entry site-enhanced green fluorescent protein cassette was inserted downstream of the E1B locus to monitor viral replication in vivo. Adenoviral replication of hTERT-Ad and enhancement of enhanced green fluorescent protein expression could be observed in all investigated telomerase-positive tumor cell lines. In contrast, hTERT-Ad infection of telomerase-negative primary human hepatocytes did not result in significant replication. The capability of hTERT-Ad to induce cytopathic effects in tumor cells was comparable with that of adenovirus wild type and significantly higher compared with ONYX-015, regardless of the p53 status of the tumor cells. Single application of low-dose hTERT-Ad to tumor xenografts led to significant inhibition of tumor growth, confirming the potential therapeutic value of conditionally replicative adenoviral vectors. These in vivo experiments also revealed that hTERT-Ad-mediated oncolysis was more efficient than ONYX-015 treatment. These results demonstrate that expression of E1A under transcriptional control of the hTERT promoter is sufficient for effective telomerase-dependent adenovirus replication as a promising perspective for the treatment of the majority of epithelial tumors.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
ScienceExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
4,963 Citations1998Andrea Bodnár, Michel Ouellette +8 more
European Journal of CancerA survey of telomerase activity in human cancer
2,770 Citations1997Jerry W. Shay, Silvia Bacchetti
All major types of cancer have been screened and the presence of telomerase activity has been detected in the vast majority of cases, and a summary, in table form, of the current data is provided.
CellTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
2,104 Citations1997Marı́a A. Blasco, Han‐Woong Lee +5 more
Results indicate that telomerase is essential for telomere length maintenance but is not required for establishment of cell lines, oncogenic transformation, or tumor formation in mice.
ScienceAn Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
1,759 Citations1996James R. Bischoff, David H. Kirn +9 more
Injection of the mutant virus into p53-deficient human cervical carcinomas grown in nude mice caused a significant reduction in tumor size and caused complete regression of 60 percent of the tumors, raising the possibility that mutant adenoviruses can be used to treat certain human tumors.
CellLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
1,331 Citations1999K. Lenhard Rudolph, Sandy Chang +5 more
A critical role for telomere length in the overall fitness, reserve, and well being of the aging organism is demonstrated.
NatureEssential role of mouse telomerase in highly proliferative organs
1,268 Citations1998Han‐Woong Lee, Marı́a A. Blasco +4 more
Findings indicate an essential role for telomerase, and hence telomeres, in the maintenance of genomic integrity and in the long-term viability of high-renewal organ systems.
Nature MedicineA controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
1,103 Citations2000Fadlo R. Khuri, John Nemunaitis +14 more
A phase II trial of a combination of intratumoral ONYX-015 injection with cisplatin and 5-fluorouracil in patients with recurrent squamous cell cancer of the head and neck found substantial objective responses, including a high proportion of complete responses.
Annual Review of BiochemistryTELOMERE LENGTH REGULATION
1,021 Citations1996Carol W. Greider
Understanding telomerase and telomere length regulation may help to understand tumor progression and allow a more complete understanding of telomeres function in the cell.
Current BiologyReconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
1,006 Citations1998Homayoun Vaziri, Samuel Benchimol
Results show that retroviral-mediated expression of hTERT resulted in functional telomerase activity in normal aging human cells, indicating that telomere length is one factor that can determine the replicative life span of human cells.
Nature GeneticsReconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
964 Citations1997Scott L. Weinrich, R. Pruzan +15 more
In vitro transcription and translation of hTRT when co-synthesized or mixed with hTR reconstitutes telomerase activity that exhibits enzymatic properties like those of the native enzyme.
Nature GeneticsDirect activation of TERT transcription by c-MYC
902 Citations1999Kou‐Juey Wu, Carla Grandori +5 more
Nature MedicineAn adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
584 Citations2000Carla Heise, Terry Hermiston +6 more
An E1A mutant adenovirus, dl922-947, is identified that replicates in and lyses a broad range of cancer cells with abnormalities in cell-cycle checkpoints, and holds promise as a potent, replication-selective virus for the local and systemic treatment of cancer.
Nature MedicineReplication-selective virotherapy for cancer: Biological principles, risk management and future directions
502 Citations2001David H. Kirn, Robert L. Martuza +1 more
The underlying biological principles and current status of the field are described, approaches for improving clinical effectiveness are outlined and the unique safety and regulatory issues surrounding viral therapies are discussed.
OncogeneTelomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
418 Citations1999Roger A. Greenberg, Rónán C. O’Hagan +8 more
It is shown that TERT is unable to substitute for c-Myc in the transformation of primary rodent fibroblasts, suggesting that the transforming activities of Myc extend beyond its ability to activate TERT gene expression and hence telomerase activity.
PubMedCloning and characterization of the promoter region of human telomerase reverse transcriptase gene.
399 Citations1999Izumi Horikawa, P. LouAnn Cable +2 more
Journal of VirologyReplication of ONYX-015, a Potential Anticancer Adenovirus, Is Independent of p53 Status in Tumor Cells
354 Citations1998Thomas Rothmann, Arnd Hengstermann +3 more
dl1520 replicates independently of the p53 status in various tumor cell lines (U87, RKO, A549, H1299, and U373) and it is shown that, depending on the multiplicity of infection, the deleted virus is able to replicate in and to kill primary human cells.
Human Gene TherapyEfficient Construction of a Recombinant Adenovirus Vector by an Improved <i>In Vitro</i> Ligation Method
335 Citations1998Hiroyuki Mizuguchi, Mark A. Kay
The large number and strategic location of the unique restriction sites will not only increase the rapidity of production of new first-generation vectors for gene transfer but will allow for rapid further improvements in the vector DNA backbone.
GeneActivity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)
275 Citations2001Joseph Poole, Lucy G. Andrews +1 more
Recent advances in the regulation of the hTERT gene are examined and discrepancies resulting from the nearly simultaneous nature of publications in this fast-moving area are examined to resolve discrepancies.
Journal of Clinical InvestigationSelectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen
238 Citations2000Toshikazu Kurihara, Douglas E. Brough +2 more
It is demonstrated that the DF3/MUC1 promoter confers competence for selective replication of Ad.DF3-E1 in MUC1-positive breast tumor cells, and that the antitumor activity of this vector is potentiated by integration of the TNF cDNA.
Nature Medicinep53-dependent cell death/apoptosis is required for a productive adenovirus infection
233 Citations1998Anthony R. Hall, Brett R. Dix +2 more
It is shown that cells expressing wt p53, as well as p53-defective cells, allow adenovirus replication, but only cellsExpression of virus-induced cytopathic effect correlates with the ability of adanovirus to induce cell death, indicating that p53 plays a necessary part in mediating cellular destruction to allow a productive adenOVirus infection.
PubMedAdenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
224 Citations2000Taro Kanaya, Satoru Kyo +5 more
It is suggested that p53 repressed telomerase activity through down-regulation of hTERT transcription and that interaction of p53 with Sp1 or other transcription factors may be involved in this regulation.
PubMedIntravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy.
192 Citations1999Carla Heise, Alan M Williams +3 more
Viral replication within tumors was associated with regressions in several tumor models and selectively replicating viruses like ONYX-015 hold promise as agents to treat metastatic cancer.
Nature MedicineLoss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
191 Citations2000Stefan Ries, Christian Brandts +6 more
This study demonstrates that the re-introduction of p14ARF into tumor cells with wild-type p53 suppresses replication of dl1520 in a p53-dependent manner, and supports the therapeutic use of d l15 20 in tumors with lesions within the p53 pathway other than mutation of p53.
PubMedTumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
187 Citations2000Jian Gu, Shunsuke Kagawa +5 more
It is shown that induction of the Bax gene expression via the hTERT promoter elicited tumor-specific apoptosis in vitro, suppressed tumor growth in nude mice, and prevented the toxicity of theBax gene in vitro and in vivo.
Journal of Biological ChemistryNFκB Mediates Apoptosis through Transcriptional Activation of Fas (CD95) in Adenoviral Hepatitis
163 Citations2000Florian Kühnel, Lars Zender +5 more
Human Gene TherapyLethal Toxicity, Severe Endothelial Injury, and a Threshold Effect with High Doses of an Adenoviral Vector in Baboons
163 Citations2002Núria Morral, Wanda K. O’Neal +7 more
Histological studies provide a detailed picture of the pathology associated with a lethal dose of first-generation adenoviral vector in a primate and injury to the vascular endothelium was the most prominent abnormality in the high-dose baboon.
PubMedA hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
149 Citations2001Yingming Li, Dechao Yu +5 more
The results support the clinical development of CV890 as an antineoplastic agent for the treatment of localized or metastatic HCC and demonstrate improvements in virus specificity equivalent to driving the E1A and E1B genes with two independent TREs yet requires only one TRE thereby conserving genomic space within the virus.
PubMedA conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
149 Citations2001Shigeji Matsubara, Yoshitaka Wada +9 more
A cotargeting strategy using a conditional replication-competent adenovirus to target the growth of tumor cells and their associated osteoblasts appears to be more effective than systemic Ad-PSE-E1a in preclinical models of human prostate cancer skeletal metastasis.
Nature BiotechnologyRe-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy
133 Citations2001Murali Ramachandra, Amena Rahman +9 more
A virus is constructed containing a novel regulatory circuit in which p53-dependent expression of an antagonist of the E2F transcription factor inhibits viral replication in normal cells, but in tumor cells, the combination of p53 pathway defects and deregulated E2f allows replication of 01/PEME at near wild-type levels.
PubMedTreatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
131 Citations2001Tadashi Komata, Yasuko Kondo +13 more
The present results strongly suggest that the telomerase-specific transfer of the rev-caspase-6 gene under the hTERT promoter is a novel targeting approach for the treatment of malignant gliomas.
Journal of General VirologyCytolytic viruses as potential anti-cancer agents
125 Citations2002C. Ring
Increasing knowledge of the pathogenesis of virus disease and the ability to manipulate specific regions of viral genomes have allowed the construction of viruses that are attenuated in normal cells but retain their ability to lyse tumour cells.
Gene TherapyThe telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters
116 Citations2001A. S. Majumdar, Douglas E. Hughes +4 more
By restricting thymidine kinase expression to tumor cells, the hTERT promoter allows the tumoricidal effect of the suicidal gene to be exerted without detrimental consequences on healthy tissues and vital organs.
Human Gene TherapyA Novel Telomerase-Specific Gene Therapy: Gene Transfer of Caspase-8 Utilizing the Human Telomerase Catalytic Subunit Gene Promoter
113 Citations2000Shoji Koga, Satoshi Hirohata +6 more
Telomerase-specific expression of apoptosis-inducible genes afforded by the hTERT promoter, utilizing the promoter of the human telomerase catalytic subunit (hTERT) gene, are developed and shown to be a novel and promising targeting approach for the treatment of tumors with telomersase activity.
PubMedThe development of conditionally replicative adenoviruses for cancer therapy.
108 Citations2000DT Curiel
An advanced understanding of the cancer phenotype, as well as achievements in functionally exploiting viral plasticity, predicate the design and realization of conditionally replicative adenoviral agents with improved characteristics for cancer therapy.
OncogeneTelomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954
100 Citations2001Jane A. Plumb, Alan Bilsland +6 more
Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954 to test the feasibility of using the transcriptional regulatory sequences from the hTERT and hTR genes to regulate expression of the bacterial nit mirroreductase enzyme in combination with the Prozac.
PubMedp53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
99 Citations1999Charles M. Vollmer, Antoni Ribas +10 more
The E1B-deleted adenoviral vector dl1520 has an apparent p53-dependent effect in HCC cell lines, however, this effect is lost at higher viral doses and only induces partial tumor regressions without tumor cures in a human HCC xenograft model.
Gene TherapyhTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity
92 Citations2002Jian Gu, Michael Andreeff +2 more
The hTERT promoter-driven, adenovirus-mediated Bax transgene expression in human CD34+ bone marrow progenitor cells had effects similar to those observed in other normal human cells, suggesting that the h TERT promoter is much less active inCD34+ cells than in tumor cells.
Molecular TherapyUse of Transcriptional Regulatory Sequences of Telomerase (hTER and hTERT) for Selective Killing of Cancer Cells
90 Citations2000Rula Abdul‐Ghani, Patricia Ohana +10 more
The feasibility of using hTER and hTERT transcriptional regulatory sequences for targeted patient-oriented gene therapy of human cancer is supported.
PubMedEfficient induction of cell death by adenoviruses requires binding of E1B55k and p53.
70 Citations2000Brett R. Dix, Simon J. O’Carroll +3 more
It is shown that formation of a complex between p53 and the adenoviral Elb55k protein is necessary for the activation of the rapid cell death pathway, and that binding of E1b 55k to p53 does not merely serve to inactivate p53, but rather is required for the induction of rapid cellDeath.
Human Gene TherapyCaspase-8 Gene Therapy Using the Human Telomerase Reverse Transcriptase Promoter for Malignant Glioma Cells
55 Citations2002Tadashi Komata, Yasuko Kondo +11 more
The results suggest that the telomersase-specific expression of caspase-8 under hTERT-378 promoter is a novel targeting approach for the treatment of telomerase-positive malignant gliomas.
Nature MedicineTumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector
54 Citations2001Dirk S. Steinwaerder, Cheryl A. Carlson +4 more
This study demonstrates activation of transgene expression exclusively in hepatic metastases after systemic application of a modified first-generation (E1A/E1B-deleted) adenovirus vector (AdE1−) in mouse tumor models.
PubMedFADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.
40 Citations2001Shoji Koga, Satoshi Hirohata +6 more
The findings described here indicate the high potentiality of a novel telomerase-specific gene therapy of tumors with telomerases, and the expression vector of FADD gene with death domain afforded by the hTERT promoter (hTERT/FADD).
International Journal of OncologyA novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter
37 Citations2001Tadashi Komata, Shoji Koga +7 more
Gene transfer of FADD under the control of the h TERT promoter may be a novel and promising therapy to kill hTERT-positive malignant glioma cells while sparing normal brain cells lacking hterT.